Cysteine Dioxygenase / CDO1 Antibody (N-Terminus)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P, E |
---|---|
Primary Accession | Q16878 |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 23kDa |
Dilution | IHC-P (10 µg/ml), WB (1-2 µg/ml), |
Gene ID | 1036 |
---|---|
Other Names | Cysteine dioxygenase type 1, 1.13.11.20, Cysteine dioxygenase type I, CDO, CDO-I, CDO1 |
Target/Specificity | CDO1 antibody is human, mouse and rat reactive. |
Reconstitution & Storage | Long term: -20°C; Short term: +4°C. Avoid repeat freeze-thaw cycles. |
Precautions | Cysteine Dioxygenase / CDO1 Antibody (N-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CDO1 |
---|---|
Function | Catalyzes the oxidation of cysteine to cysteine sulfinic acid with addition of molecular dioxygen. |
Tissue Location | Highly expressed in liver and placenta. Low expression in heart, brain and pancreas. Also detected in hepatoblastoma Hep-G2 cells. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Initiates several important metabolic pathways related to pyruvate and several sulfurate compounds including sulfate, hypotaurine and taurine. Critical regulator of cellular cysteine concentrations. Has an important role in maintaining the hepatic concentation of intracellular free cysteine within a proper narrow range.
References
McCann K.P.,et al.Biochim. Biophys. Acta 1209:107-110(1994).
Tsuboyama-Kasaoka N.,et al.Biosci. Biotechnol. Biochem. 63:1017-1024(1999).
Ramsden D.B.,et al.Mol. Pathol. 50:269-271(1997).
Halleck A.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.